MedPath

Rapid Assessment of Potential Interventions & Drugs for Ebola (RAPIDE) ¿ TKM

Not Applicable
Conditions
Ebola
Registration Number
PACTR201501000997429
Lead Sponsor
niversity of Oxford
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Laboratory confirmed infection with Ebolavirus
Informed consent provided by patient >18 years) or representative (too unwell)
Informed consent from parent or guardian (child)
Has no underlying condition that could jeopardize patient or staff safety
Able to comply with protocol requirements

Exclusion Criteria

None

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TKM: To evaluate the impact of TKM treatment on early mortality in EVD;Observational: To characterize the early mortality of EVD in an ETC
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath